Genetic testing leads to response in MET fusion lung cancer
Researchers have identified a rare fusion involving the gene MET leading researchers to treat the cancer with a targeted therapy...
List view / Grid view
Researchers have identified a rare fusion involving the gene MET leading researchers to treat the cancer with a targeted therapy...
Study from NIH may help improve prenatal genetic screening...
Researchers have determined that a specific region of the duodenal-jejunal flexure, shows a high frequency of gastrointestinal stromal tumours with mutations of the NF1 gene...
Researchers have shown that catching and treating breast cancer before it spreads is now a realistic goal...
A research team have discovered that in the Cancer Genome Atlas database the gene expression in reference samples differs from normal tissue, depending on where in the kidney the samples happen to have been taken from...
The National Institutes of Health is awarding $18.9 million towards research that aims to accelerate the use of genome sequencing in clinical care...
Researchers have used CRISPR to stop the expression of individual genes in cancer cells, by knocking out every known protein-encoding gene in the human genome...
Specific genetic factors have been found to be the cause of epilepsy in 40 percent of patients evaluated with seizures...
Researchers have found a pattern of genes which is characteristic of osteoarthritis and may be a step towards better treatments for this condition.
A new study conducted by an international team of lung cancer researchers have identified new genetic variants for lung cancer risk.
The ubiquitous human herpes virus 6 (HHV-6) may play a critical role in impeding the brain's ability to repair itself in diseases like multiple sclerosis.
Moving genes about could help cells to respond to change according to scientists at the Babraham Institute in Cambridge, UK and the Weizmann Institute, Israel.
This latest funding round attracts two prominent new investors; Brian Kennedy and Sir Brian Souter.
MRC-funded researchers have identified properties in DNA’s protective structure that could transform the way scientists think about the human genome.
NIH-supported research suggests potential treatment strategy following the identification of single-gene mutations that lead to eczema.